These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29249175)

  • 1. A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cells.
    Oo ZM; Illendula A; Grembecka J; Schmidt C; Zhou Y; Esain V; Kwan W; Frost I; North TE; Rajewski RA; Speck NA; Bushweller JH
    Leuk Lymphoma; 2018 Sep; 59(9):2188-2200. PubMed ID: 29249175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CBFbeta is critical for AML1-ETO and TEL-AML1 activity.
    Roudaia L; Cheney MD; Manuylova E; Chen W; Morrow M; Park S; Lee CT; Kaur P; Williams O; Bushweller JH; Speck NA
    Blood; 2009 Mar; 113(13):3070-9. PubMed ID: 19179469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction.
    Cunningham L; Finckbeiner S; Hyde RK; Southall N; Marugan J; Yedavalli VR; Dehdashti SJ; Reinhold WC; Alemu L; Zhao L; Yeh JR; Sood R; Pommier Y; Austin CP; Jeang KT; Zheng W; Liu P
    Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14592-7. PubMed ID: 22912405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers.
    Illendula A; Gilmour J; Grembecka J; Tirumala VSS; Boulton A; Kuntimaddi A; Schmidt C; Wang L; Pulikkan JA; Zong H; Parlak M; Kuscu C; Pickin A; Zhou Y; Gao Y; Mishra L; Adli M; Castilla LH; Rajewski RA; Janes KA; Guzman ML; Bonifer C; Bushweller JH
    EBioMedicine; 2016 Jun; 8():117-131. PubMed ID: 27428424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RUNX1 is required for oncogenic
    Choi A; Illendula A; Pulikkan JA; Roderick JE; Tesell J; Yu J; Hermance N; Zhu LJ; Castilla LH; Bushweller JH; Kelliher MA
    Blood; 2017 Oct; 130(15):1722-1733. PubMed ID: 28790107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of RUNX1/CBFβ by MLL fusion proteins enhances hematopoietic stem cell self-renewal.
    Zhao X; Chen A; Yan X; Zhang Y; He F; Hayashi Y; Dong Y; Rao Y; Li B; Conway RM; Maiques-Diaz A; Elf SE; Huang N; Zuber J; Xiao Z; Tse W; Tenen DG; Wang Q; Chen W; Mulloy JC; Nimer SD; Huang G
    Blood; 2014 Mar; 123(11):1729-38. PubMed ID: 24449215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and Biophysics of CBFβ/RUNX and Its Translocation Products.
    Tahirov TH; Bushweller J
    Adv Exp Med Biol; 2017; 962():21-31. PubMed ID: 28299648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RUNX1::ETO and CBFβ::MYH11 converge on aberrant activation of BCAT1 to confer a therapeutic vulnerability in core-binding factor-acute myeloid leukaemia.
    Wang S; Liu Y; Zhao X; Wang X; Lou J; Jin P; Zhang Y; Yu J; Wang K
    Br J Haematol; 2024 Aug; 205(2):552-567. PubMed ID: 38802066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression.
    Yeh JR; Munson KM; Chao YL; Peterson QP; Macrae CA; Peterson RT
    Development; 2008 Jan; 135(2):401-10. PubMed ID: 18156164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties.
    Zent C; Kim N; Hiebert S; Zhang DE; Tenen DG; Rowley JD; Nucifora G
    Curr Top Microbiol Immunol; 1996; 211():243-52. PubMed ID: 8585955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta.
    Tahirov TH; Inoue-Bungo T; Morii H; Fujikawa A; Sasaki M; Kimura K; Shiina M; Sato K; Kumasaka T; Yamamoto M; Ishii S; Ogata K
    Cell; 2001 Mar; 104(5):755-67. PubMed ID: 11257229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells.
    Morita K; Noura M; Tokushige C; Maeda S; Kiyose H; Kashiwazaki G; Taniguchi J; Bando T; Yoshida K; Ozaki T; Matsuo H; Ogawa S; Liu PP; Nakahata T; Sugiyama H; Adachi S; Kamikubo Y
    Sci Rep; 2017 Nov; 7(1):16604. PubMed ID: 29192243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs.
    Mandoli A; Singh AA; Prange KHM; Tijchon E; Oerlemans M; Dirks R; Ter Huurne M; Wierenga ATJ; Janssen-Megens EM; Berentsen K; Sharifi N; Kim B; Matarese F; Nguyen LN; Hubner NC; Rao NA; van den Akker E; Altucci L; Vellenga E; Stunnenberg HG; Martens JHA
    Cell Rep; 2016 Nov; 17(8):2087-2100. PubMed ID: 27851970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome Profiling of Pediatric Core Binding Factor AML.
    Hsu CH; Nguyen C; Yan C; Ries RE; Chen QR; Hu Y; Ostronoff F; Stirewalt DL; Komatsoulis G; Levy S; Meerzaman D; Meshinchi S
    PLoS One; 2015; 10(9):e0138782. PubMed ID: 26397705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Honokiol induces proteasomal degradation of AML1-ETO oncoprotein via increasing ubiquitin conjugase UbcH8 expression in leukemia.
    Zhou B; Li H; Xing C; Ye H; Feng J; Wu J; Lu Z; Fang J; Gao S
    Biochem Pharmacol; 2017 Mar; 128():12-25. PubMed ID: 28043811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mutation in the S-switch region of the Runt domain alters the dynamics of an allosteric network responsible for CBFbeta regulation.
    Li Z; Lukasik SM; Liu Y; Grembecka J; Bielnicka I; Bushweller JH; Speck NA
    J Mol Biol; 2006 Dec; 364(5):1073-83. PubMed ID: 17059830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charged Amino Acid-rich Leucine Zipper-1 (Crlz-1) as a Target of Wnt Signaling Pathway Controls Pre-B Cell Proliferation by Affecting Runx/CBFβ-targeted VpreB and λ5 Genes.
    Choi SY; Park SK; Yoo HW; Pi JH; Kang CJ
    J Biol Chem; 2016 Jul; 291(29):15008-19. PubMed ID: 27226553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Basis and Targeted Inhibition of CBFβ-SMMHC Acute Myeloid Leukemia.
    Castilla LH; Bushweller JH
    Adv Exp Med Biol; 2017; 962():229-244. PubMed ID: 28299661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Core Binding Factor-β Knockdown Alters Ovarian Gene Expression and Function in the Mouse.
    Wilson K; Park J; Curry TE; Mishra B; Gossen J; Taniuchi I; Jo M
    Mol Endocrinol; 2016 Jul; 30(7):733-47. PubMed ID: 27176614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.